Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 5 | 2024 | 62 | 2.060 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 40 | 0.850 |
Why?
|
| Epilepsy | 3 | 2023 | 421 | 0.840 |
Why?
|
| Seizures | 2 | 2022 | 305 | 0.840 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2024 | 51 | 0.820 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 3441 | 0.820 |
Why?
|
| Internal Capsule | 1 | 2021 | 9 | 0.800 |
Why?
|
| Thalamus | 1 | 2023 | 134 | 0.790 |
Why?
|
| Laser Therapy | 2 | 2020 | 149 | 0.780 |
Why?
|
| Neurosurgical Procedures | 2 | 2021 | 232 | 0.770 |
Why?
|
| Neuronavigation | 1 | 2019 | 22 | 0.670 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2021 | 162 | 0.670 |
Why?
|
| Basal Ganglia | 1 | 2019 | 46 | 0.670 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 188 | 0.610 |
Why?
|
| Electroencephalography | 1 | 2022 | 749 | 0.600 |
Why?
|
| Electric Impedance | 2 | 2014 | 110 | 0.570 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 227 | 0.570 |
Why?
|
| Parkinson Disease | 2 | 2018 | 144 | 0.560 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2015 | 2 | 0.510 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 56 | 0.500 |
Why?
|
| Rotation | 1 | 2015 | 91 | 0.500 |
Why?
|
| Hearing Loss | 1 | 2015 | 59 | 0.490 |
Why?
|
| Hearing Disorders | 1 | 2014 | 8 | 0.490 |
Why?
|
| Hearing Tests | 1 | 2014 | 11 | 0.490 |
Why?
|
| Brain Diseases | 1 | 2016 | 185 | 0.490 |
Why?
|
| Cell Death | 1 | 2015 | 262 | 0.480 |
Why?
|
| Myelin Sheath | 1 | 2015 | 85 | 0.480 |
Why?
|
| Meningomyelocele | 1 | 2014 | 22 | 0.480 |
Why?
|
| Locomotion | 1 | 2015 | 138 | 0.480 |
Why?
|
| Hydrocephalus | 1 | 2015 | 104 | 0.480 |
Why?
|
| Electrodes | 1 | 2014 | 88 | 0.470 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2014 | 43 | 0.460 |
Why?
|
| Recovery of Function | 1 | 2015 | 292 | 0.460 |
Why?
|
| Brain Injuries | 1 | 2016 | 164 | 0.460 |
Why?
|
| Brain Stem | 1 | 2014 | 167 | 0.450 |
Why?
|
| Neonatal Screening | 1 | 2014 | 62 | 0.450 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 386 | 0.440 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 177 | 0.430 |
Why?
|
| Gene Expression | 1 | 2015 | 1309 | 0.380 |
Why?
|
| Inflammation | 1 | 2015 | 969 | 0.350 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1222 | 0.330 |
Why?
|
| Neurons | 2 | 2023 | 1576 | 0.310 |
Why?
|
| Corpus Callosum | 2 | 2020 | 59 | 0.300 |
Why?
|
| Brain | 2 | 2016 | 2269 | 0.290 |
Why?
|
| Humans | 15 | 2024 | 88835 | 0.240 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2024 | 3 | 0.240 |
Why?
|
| Female | 10 | 2024 | 45893 | 0.230 |
Why?
|
| Male | 10 | 2024 | 42127 | 0.230 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2023 | 9 | 0.220 |
Why?
|
| Treatment Outcome | 4 | 2023 | 8177 | 0.210 |
Why?
|
| Somatosensory Cortex | 1 | 2023 | 135 | 0.200 |
Why?
|
| Postoperative Period | 1 | 2022 | 301 | 0.200 |
Why?
|
| Motor Cortex | 1 | 2023 | 199 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2021 | 71 | 0.190 |
Why?
|
| Young Adult | 3 | 2024 | 6271 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2023 | 778 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2023 | 865 | 0.180 |
Why?
|
| Middle Aged | 6 | 2024 | 25783 | 0.180 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2020 | 15 | 0.180 |
Why?
|
| Microelectrodes | 2 | 2024 | 83 | 0.180 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 80 | 0.170 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2020 | 131 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 27 | 0.150 |
Why?
|
| Subthalamic Nucleus | 1 | 2018 | 23 | 0.150 |
Why?
|
| Folic Acid | 1 | 2018 | 63 | 0.150 |
Why?
|
| Glutamine | 1 | 2018 | 79 | 0.150 |
Why?
|
| Postoperative Complications | 2 | 2019 | 2273 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2018 | 119 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2018 | 183 | 0.140 |
Why?
|
| Antimanic Agents | 1 | 2016 | 13 | 0.140 |
Why?
|
| Rats, Nude | 1 | 2015 | 25 | 0.130 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 589 | 0.130 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2015 | 24 | 0.130 |
Why?
|
| Iduronidase | 1 | 2015 | 2 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 595 | 0.130 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2015 | 52 | 0.120 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2014 | 3 | 0.120 |
Why?
|
| Adult | 4 | 2024 | 26437 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2018 | 605 | 0.120 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2014 | 18 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 368 | 0.120 |
Why?
|
| Medical Records | 1 | 2014 | 120 | 0.120 |
Why?
|
| Heterozygote | 1 | 2015 | 373 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 978 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2020 | 8960 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1236 | 0.110 |
Why?
|
| Brain Mapping | 1 | 2016 | 564 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2015 | 377 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1590 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3649 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 5311 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1712 | 0.090 |
Why?
|
| Rats | 1 | 2015 | 4039 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2347 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2464 | 0.080 |
Why?
|
| Infant | 1 | 2014 | 3130 | 0.080 |
Why?
|
| Prognosis | 1 | 2014 | 3756 | 0.070 |
Why?
|
| Animals | 2 | 2015 | 27272 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2023 | 354 | 0.050 |
Why?
|
| Hand | 1 | 2023 | 133 | 0.050 |
Why?
|
| Movement | 1 | 2023 | 307 | 0.050 |
Why?
|
| Mice | 1 | 2015 | 11722 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2020 | 15 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 338 | 0.040 |
Why?
|
| NAD | 1 | 2018 | 68 | 0.040 |
Why?
|
| Catalysis | 1 | 2018 | 205 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 389 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 351 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 385 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 486 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1527 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 885 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1713 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1294 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 4255 | 0.020 |
Why?
|
| Child | 1 | 2020 | 7112 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 9201 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 19014 | 0.010 |
Why?
|